[1]
“Clinical Outcome of Intravenous Immunoglobulin in the treatment of Guillain Barre Syndrome in a Nepalese Tertiary Centre”, Nep. Med. J., vol. 2, no. 1, pp. 133–137, Jun. 2019, doi: 10.3126/nmj.v2i1.24000.